Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
3.83
HKD
|
+4.08%
|
|
+6.09%
|
-45.67%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,433
|
5,305
|
2,935
|
-
|
-
|
Enterprise Value (EV)
1 |
4,868
|
3,519
|
1,021
|
604
|
208.3
|
P/E ratio
|
43.9
x
|
16.5
x
|
9.01
x
|
7.54
x
|
6.89
x
|
Yield
|
-
|
1.44%
|
2.54%
|
2.85%
|
4.46%
|
Capitalization / Revenue
|
6.77
x
|
4.79
x
|
2.3
x
|
1.98
x
|
1.82
x
|
EV / Revenue
|
5.12
x
|
3.18
x
|
0.8
x
|
0.41
x
|
0.13
x
|
EV / EBITDA
|
28.4
x
|
11.1
x
|
2.69
x
|
1.38
x
|
0.49
x
|
EV / FCF
|
34.5
x
|
-
|
3.02
x
|
1.65
x
|
0.64
x
|
FCF Yield
|
2.9%
|
-
|
33.1%
|
60.8%
|
155%
|
Price to Book
|
-
|
-
|
0.98
x
|
0.86
x
|
0.73
x
|
Nbr of stocks (in thousands)
|
827,770
|
827,968
|
827,968
|
-
|
-
|
Reference price
2 |
7.772
|
6.408
|
3.545
|
3.545
|
3.545
|
Announcement Date
|
3/8/23
|
3/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
950.9
|
1,107
|
1,277
|
1,483
|
1,616
|
EBITDA
1 |
-
|
171.6
|
317.7
|
380.2
|
436.3
|
428.1
|
EBIT
1 |
-
|
146.5
|
287.5
|
348.2
|
403.5
|
398.4
|
Operating Margin
|
-
|
15.4%
|
25.96%
|
27.27%
|
27.21%
|
24.66%
|
Earnings before Tax (EBT)
1 |
-
|
151.4
|
357.2
|
427.9
|
510.6
|
626
|
Net income
1 |
-31.01
|
128.5
|
324.4
|
335.8
|
385.9
|
419.9
|
Net margin
|
-
|
13.51%
|
29.29%
|
26.29%
|
26.03%
|
25.99%
|
EPS
2 |
-0.0105
|
0.1772
|
0.3894
|
0.3933
|
0.4700
|
0.5145
|
Free Cash Flow
1 |
-
|
141.2
|
-
|
338.2
|
367
|
323.8
|
FCF margin
|
-
|
14.85%
|
-
|
26.48%
|
24.75%
|
20.04%
|
FCF Conversion (EBITDA)
|
-
|
82.28%
|
-
|
88.95%
|
84.11%
|
75.64%
|
FCF Conversion (Net income)
|
-
|
109.86%
|
-
|
100.73%
|
95.1%
|
77.12%
|
Dividend per Share
2 |
-
|
-
|
0.0921
|
0.0900
|
0.1010
|
0.1580
|
Announcement Date
|
12/12/22
|
3/8/23
|
3/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 S2
|
2023 S1
|
2023 S2
|
---|
Net sales
1 |
472.7
|
593.6
|
521.5
|
EBITDA
|
-
|
-
|
-
|
EBIT
1 |
70.61
|
175.8
|
113.9
|
Operating Margin
|
14.94%
|
29.62%
|
21.85%
|
Earnings before Tax (EBT)
1 |
84.15
|
204.4
|
155.5
|
Net income
1 |
72.69
|
183.6
|
143.2
|
Net margin
|
15.38%
|
30.93%
|
27.45%
|
EPS
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
3/8/23
|
8/17/23
|
3/7/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,565
|
1,786
|
1,914
|
2,331
|
2,727
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
141
|
-
|
338
|
367
|
324
|
ROE (net income / shareholders' equity)
|
-
|
7.31%
|
13.4%
|
11.9%
|
12.2%
|
11.7%
|
ROA (Net income/ Total Assets)
|
-
|
5.97%
|
12.1%
|
11%
|
11.3%
|
10.9%
|
Assets
1 |
-
|
2,153
|
2,675
|
3,066
|
3,408
|
3,870
|
Book Value Per Share
2 |
-
|
-
|
-
|
3.620
|
4.110
|
4.860
|
Cash Flow per Share
2 |
-
|
-
|
-
|
0.4300
|
0.4300
|
-
|
Capex
1 |
-
|
19.9
|
-
|
102
|
96.9
|
27
|
Capex / Sales
|
-
|
2.1%
|
-
|
8%
|
6.53%
|
1.67%
|
Announcement Date
|
12/12/22
|
3/8/23
|
3/7/24
|
-
|
-
|
-
|
Last Close Price
3.545
CNY Average target price
6.393
CNY Spread / Average Target +80.33% Consensus |
1st Jan change
|
Capi.
|
---|
| -45.67% | 405M | | +12.07% | 128B | | -9.04% | 10.65B | | +0.91% | 8.82B | | +16.72% | 7.19B | | +25.15% | 4.99B | | +7.17% | 3.4B | | -1.36% | 3.03B | | -8.73% | 2.14B | | -10.15% | 2B |
Medical Devices & Implants
|